Anbio Operating Income from 2010 to 2026
| NNNN Stock | 35.69 0.70 2.00% |
Operating Income | First Reported 2010-12-31 | Previous Quarter 1.8 M | Current Value 3.3 M | Quarterly Volatility 1.9 M |
Check Anbio Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anbio Biotechnology's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 407.5 K or Interest Income of 407.5 K, as well as many indicators such as Price To Sales Ratio of 32.57, Dividend Yield of 0.0 or PTB Ratio of 15.51. Anbio financial statements analysis is a perfect complement when working with Anbio Biotechnology Valuation or Volatility modules.
Anbio | Operating Income | Build AI portfolio with Anbio Stock |
Latest Anbio Biotechnology's Operating Income Growth Pattern
Below is the plot of the Operating Income of Anbio Biotechnology Class over the last few years. Operating Income is the amount of profit realized from Anbio Biotechnology Class operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Anbio Biotechnology Class is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Anbio Biotechnology's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anbio Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Anbio Operating Income Regression Statistics
| Arithmetic Mean | 2,867,047 | |
| Geometric Mean | 2,601,563 | |
| Coefficient Of Variation | 66.79 | |
| Mean Deviation | 915,653 | |
| Median | 2,455,878 | |
| Standard Deviation | 1,914,928 | |
| Sample Variance | 3.7T | |
| Range | 8.4M | |
| R-Value | 0.18 | |
| Mean Square Error | 3.8T | |
| R-Squared | 0.03 | |
| Significance | 0.49 | |
| Slope | 68,691 | |
| Total Sum of Squares | 58.7T |
Anbio Operating Income History
About Anbio Biotechnology Financial Statements
Anbio Biotechnology investors utilize fundamental indicators, such as Operating Income, to predict how Anbio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | 1.8 M | 3.3 M |
Pair Trading with Anbio Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anbio Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anbio Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Anbio Stock
The ability to find closely correlated positions to Anbio Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anbio Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anbio Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anbio Biotechnology Class to buy it.
The correlation of Anbio Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anbio Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anbio Biotechnology Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anbio Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Anbio Biotechnology Correlation against competitors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.028 | Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.22) | Return On Assets |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anbio Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.